Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Intrahepatic Cholangiocarcinoma”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)Looking for participantsNCT06296563
What this trial is testing

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Lei ZHAO 20
Not applicableLooking for participantsNCT04556214
What this trial is testing

Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Oslo University Hospital 15
Testing effectiveness (Phase 2)UnknownNCT04523402
What this trial is testing

Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis

Who this might be right for
Intrahepatic Cholangiocarcinoma Recurrent
Eastern Hepatobiliary Surgery Hospital 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04669496
What this trial is testing

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Intrahepatic CholangiocarcinomaPD1 AntibodyLenvatinib+1 more
Shanghai Zhongshan Hospital 178
Testing effectiveness (Phase 2)Looking for participantsNCT06721286
What this trial is testing

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06569225
What this trial is testing

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Who this might be right for
Cholangiocarcinoma Resectable
University Health Network, Toronto 40
Testing effectiveness (Phase 2)WithdrawnNCT06017297
What this trial is testing

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

Who this might be right for
Borderline Resectable CarcinomaBiliary Tract Cancer
Georgetown University
Post-approval studies (Phase 4)Not Yet RecruitingNCT06417606
What this trial is testing

Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Zhiyong Huang 20
Testing effectiveness (Phase 2)UnknownNCT04506281
What this trial is testing

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 128
Not applicableLooking for participantsNCT06098547
What this trial is testing

LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Azienda Sanitaria Ospedaliera 10
Early research (Phase 1)WithdrawnNCT02856568
What this trial is testing

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Non-Resectable CholangiocarcinomaRecurrent CholangiocarcinomaStage III Extrahepatic Bile Duct Cancer+10 more
Mayo Clinic
Testing effectiveness (Phase 2)WithdrawnNCT04546828
What this trial is testing

A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea

Who this might be right for
Intrahepatic Cholangiocarcinoma
Samsung Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05967182
What this trial is testing

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT06192797
What this trial is testing

Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Tongji Hospital 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06903273
What this trial is testing

Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBiliary Tract Cancer (BTC)
National Cheng-Kung University Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT06280508
What this trial is testing

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Not applicableStudy completedNCT06381648
What this trial is testing

Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

Who this might be right for
CholangiocarcinomaCholangiocarcinoma, IntrahepaticCholangiocarcinoma Resectable+1 more
City of Hope Medical Center 230
Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Early research (Phase 1)Ended earlyNCT01525069
What this trial is testing

Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaLiver Neoplasms
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Looking for participantsNCT05557578
What this trial is testing

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Who this might be right for
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital 20
Load More Results